1. Denmark Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
GN Store Nord A/S

GN Store Nord A/S

GN.CO
GN Store Nord A/SDK flagNASDAQ Copenhagen
92.20
DKK
+3.64
- -
13.43BMarket Cap
GN Store Nord A/S
GN.CO
(NASDAQ Copenhagen)

Recent

price

92.20

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
25.39
27.72
34.96
40.64
45.24
49.71
58.47
68.97
79.09
96.16
104.41
122.46
146.19
130.47
123.51
115.25
107.31
Revenue per Share
9.15
4.31
1.8
4.4
4.89
5.16
6.98
8.51
9.25
11.12
9.72
13.63
4
1.64
6.79
4.48
6
Basic EPS, GAAP
0.99
1.5
15.74
1.86
4.35
4.17
7.3
8.67
10.05
9.64
16.4
4.56
-8.14
8.68
9.07
7.81
6.56
Free Cash Flow per Basic Share
- -
0.19
0.28
0.5
0.85
0.91
1.01
1.16
1.26
1.36
1.45
1.46
1.63
0.23
- -
0.58
- -
Dividend per Share
25.48
29.47
34.09
39.99
45.14
49.46
50.95
53.76
63.95
68.74
78.67
84.18
86.55
96.38
97.96
102.17
99.89
Book Value per Share
12.2
13.1
7.31
5.05
4.51
1.89
-6.09
-10.51
-11.17
-19.68
-14.2
-16.36
-84.07
-52.84
-44.6
-42.15
-43.96
Tangible Book Value per Share
203
201
179
167
162
156
148
139
134
131
129
129
128
139
146
146
146
Basic Weighted Avg Shares
5,145
5,564
6,251
6,791
7,340
7,755
8,651
9,585
10,607
12,574
13,449
15,775
18,687
18,120
17,985
16,782
15,626
Sales/Revenue/Turnover
49.93
22.57
9.37
16.74
16.42
16.88
17.04
16.65
16.98
16.09
12.13
15.17
5.99
5.2
9.94
9.52
10.05
Operating Margin (%)
379
484
442
398
527
599
666
632
690
1,074
1,167
1,192
1,534
1,729
1,379
1,336
1,258
Depreciation Expense
1,855
865
321
735
793
805
1,033
1,183
1,241
1,454
1,252
1,756
511
228
988
653
874
Net Income, GAAP
26.85
29.39
30.37
28.15
28.94
26.48
22.15
25.4
22.35
23.26
21.28
21.18
21.38
22.45
22.19
22.32
22.19
Effective Tax Rate (%)
36.05
15.55
5.14
10.82
10.8
10.38
11.94
12.34
11.7
11.56
9.31
11.13
2.73
1.26
5.49
3.89
5.59
Profit Margin (%)
3,044
3,852
890
1,073
962
1,207
1,623
1,199
1,223
1,235
1,488
5,833
-2,368
-5,458
1,177
1,324
1,106
Working Capital
1,056
1,374
276
1,216
1,675
2,297
3,527
3,508
3,842
5,702
5,393
9,824
10,128
3,738
9,398
8,895
9,037
LT Debt
6,504
6,878
5,542
5,330
5,667
5,764
5,620
4,783
5,096
4,849
5,178
6,229
6,800
9,587
10,824
10,898
10,448
Total Equity
28.26
11.05
5.68
12.98
12.1
12.3
13.18
13.54
16.2
14.97
11.23
13.12
4.32
3.16
6.11
5.64
5.43
Return on Invested Capital (%)
36.07
12.94
4.69
10.4
9.62
8.86
10.19
11.08
10.89
10.72
8.05
9.34
2.41
1.63
4.6
3.51
4.56
Return on Capital (%)
43.86
15.62
5.35
11.51
11.33
10.71
13.54
15.76
15.47
16.56
13.1
16.74
4.67
1.87
7.15
4.48
6.17
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
2,089
2,658
2,749
LT Borrowings
9,036
8,758
8,707
LT Finance Leases
362
355
330
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
146
146
146
Market Capitalization
19,476
15,588
14,197

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
9,328
8,889
8,994
Cash, Cash Equivalents & STI
980
787
1,130
Accounts Receivable, Net
4,673
4,282
4,238
Inventories
2,585
2,572
2,402
Total Current Liabilities
8,151
7,893
7,888
Payables & Accruals
- -
- -
- -
ST Debt
2,089
2,658
2,749
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.51%
16.81%
0.68%
Free Cash Flow
-41.87%
-113.89%
-13.93%
Net Income, GAAP
26.44%
42.68%
-33.91%
Sales/Revenue/Turnover
8.38%
5.06%
-6.69%
Total Cash Common Dividend
- -
- -
165.62%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4,303
4,499
4,164
5,019
17,985
2025
2,283
4,160
4,678
- -
16,782
2026
2,096
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.74
0.66
1.86
- -
6.79
2025
0.49
1.13
- -
- -
4.48
2026
-6.56
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
0.58
2026
- -
- -
- -
- -
- -
Similar Companies
FUJIFILM Holdings Corporation (FUJIF)
Ra Medical Systems, Inc. (RMED)
Accuray Incorporated (ARAY)
EL.En. S.p.A. (ELEAF)
NAYA Biosciences, Inc. (NAYA)
Salona Global Medical Device Corporation (SGMD.V)
Business
GN Store Nord A/S, headquartered in Ballerup, Denmark, and founded in 1869, develops and manufactures intelligent hearing aids, headsets, speakerphones, videobars, and gaming peripherals; its core offerings span hearing technology under brands including ReSound, Beltone, Interton, and Danavox; professional and consumer audio solutions such as office, collaboration, contact center, gaming via SteelSeries and BlueParrott, and hearing protection products under the Jabra brand; the company serves medical, professional, enterprise, and consumer segments across approximately 100 countries with sales distributed primarily in Europe (41%), North America (38%), and the rest of the world (21%). GN operates through GN Hearing and GN Audio divisions, with manufacturing in Denmark, China, and Malaysia, and outsourced production in Southeast Asia. In recent developments, GN divested its Danish hearing aid retailer Dansk HøreCenter to Demant in August 2024, completing a multi-year strategy to exit retail operations and focus on wholesale manufacturing and partnerships with independent dispensers; the company reorganized its global manufacturing, sourcing, and supply chain in 2024 to enhance synergies, operational resilience, and flexibility amid geopolitical uncertainties; additionally, GN advanced its AI-driven technology leadership through partnerships with major tech firms including Microsoft, Zoom, Google, and Apple, while reporting solid Q3 2025 financials with 1% organic growth, 11% EBITA margin, and DKK 410 million cash flow.